Colistimethate and Urinary tract infection - a phase IV clinical study of FDA data

Summary:

Urinary tract infection is reported as a side effect among people who take Colistimethate (colistimethate sodium), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Fentanyl, and have Nausea.

The phase IV clinical study analyzes which people have Urinary tract infection when taking Colistimethate. It is created by eHealthMe based on reports of 1,500 people who have side effects when taking Colistimethate from the FDA, and is updated regularly.

What is Colistimethate?

Colistimethate has active ingredients of colistimethate sodium. eHealthMe is studying from 1,502 Colistimethate users. Check the latest studies of Colistimethate.

What is Urinary tract infection?

Urinary tract infection is found to be associated with 3,014 drugs and 3,957 conditions by eHealthMe. Check the latest studies of Urinary tract infection.

On Aug, 01, 2026

1,500 people reported to have side effects when taking Colistimethate.
Among them, 15 people (1.0%) have Urinary tract infection.

Could Colistimethate cause Urinary tract infection?

Among these 15 people:

How long have people been on Colistimethate when they have Urinary tract infection? *

What is the gender of people who have Urinary tract infection when taking Colistimethate? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Urinary tract infection when taking Colistimethate? *

What are other drugs people take besides Colistimethate? *

What are other side effects people have besides Urinary tract infection? *

Fever: 4 people, 26.67%
Skin Necrosis (skin damage): 3 people, 20.00%
Pleural Effusion (water on the lungs): 3 people, 20.00%
Cholangitis Sclerosing (infection and obstruction of bile duct): 3 people, 20.00%
Pneumonia Klebsiella (pneumonia caused by bacteria klebsiella): 3 people, 20.00%
Ascites (accumulation of fluid in the abdominal cavity): 3 people, 20.00%
Septic Shock (shock due to blood infection): 3 people, 20.00%
Shunt Stenosis (narrowing of shunt): 3 people, 20.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 13.33%
Nausea (feeling of having an urge to vomit): 2 people, 13.33%

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 4 people, 26.67%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 3 people, 20.00%
Nausea And Vomiting: 3 people, 20.00%
Escherichia Infection (bacterial infection by escherichia coli): 2 people, 13.33%
Acinetobacter Infection (infection by group of bacteria commonly found in soil and water): 2 people, 13.33%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 2 people, 13.33%
Pneumonia: 1 person, 6.67%
Hyperglycemia (high blood sugar): 1 person, 6.67%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 6.67%
Arthritis Bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Colistimethate and have Urinary tract infection?

- Check whether Urinary tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Colistimethate:

Colistimethate (1,502 reports)

Browse all side effects of Colistimethate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary tract infection:

Urinary tract infection (3,014 drugs)

Browse all the conditions that are associated with Urinary tract infection:

Urinary tract infection (3,957 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on colistimethate sodium (the active ingredients of Colistimethate) and Colistimethate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.